Hematology/Medical Oncology Fellows Conference (MSH) APP Grand Rounds: CHIP, Inflammation, and LGL: Review of cytopenias with myeloma and cell therapy

Wednesday, January 20, 2027, 5:00 PM - 6:00 PM, New York , NY


Fellows present clinically based, mentored scholarly talks with a subset (25% of total presentations) focused on QA/QI topics)

1. Define clonal hematopoiesis as a driver in cytopenias and systemic inflammation, and its role in multiple patients
2. Discuss inflammatory cytopenias after T cell redirection therapy, including LGL and T cell clonal expansion
3. Review pathways of MDS/AML development in myeloma after transplant and CAR-T

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
1/20/2027 5:00:00 PM	Hematology/Medical Oncology Fellows Conference (MSH) APP Grand Rounds: CHIP, Inflammation, and LGL: Review of cytopenias with myeloma and cell therapy 1/20/2027 5:00:00 PM 1/20/2027 6:00:00 PM 15 False MM/DD/YYYY	Hematology/Medical Oncology Fellows Conference (MSH) APP Grand Rounds: CHIP, Inflammation, and LGL: Review of cytopenias with myeloma and cell therapy Fellows present clinically based, mentored scholarly talks with a subset (25% of total presentations) focused on QA/QI topics) Specialties: Academic/Research, Hematology, Oncology